Vulnerabilities

Vulnerability · CVE-2025-3981

A vulnerability, which was classified as problematic, has been found in wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0.

Published Apr 27, 2025 · catalog updated Apr 28, 2025 · wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System

Check if you run it

No confirmed exploitation is on record for CVE-2025-3981. EPSS is 0.37%. Act only if a listed version of wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.37%
Remediation
Vendor / distro source
Affected products
vendor wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0

A vulnerability, which was classified as problematic, has been found in wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0. This issue affects some unknown processing of the file /v1/prescription/details/. The manipulation leads to improper authorization. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.01.0

How to fix CVE-2025-3981

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-3981. EPSS is 0.37%. Act only if a listed version of wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System is installed.

Which versions are affected?

Compare what you have installed with wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0 1.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.37%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 27, 2025 · EUVD

    Detected

    A vulnerability, which was classified as problematic, has been found in wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0. This issue affects some unknown processing of the file /v1/prescription/details/. The manipulation leads to improper authorization. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early abo

  2. Apr 28, 2025 · EUVD

    Updated

    A vulnerability, which was classified as problematic, has been found in wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0. This issue affects some unknown processing of the file /v1/prescription/details/. The manipulation leads to improper authorization. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early abo

Sources

  • CVE.orgVulnerability recordCVE-2025-3981

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-3981

    30-day exploitation probability 0.4%

    first.org
  • EUVDVulnerability recordEUVD-2025-12433

    A vulnerability, which was classified as problematic, has been found in wowjoy 浙江湖州华卓信息科技有限公司 Internet Doctor Workstation System 1.0. This issue affects some unknown processing of the file /v1/prescription/details/. The manipulation leads to improper authorization. The attack may

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.